CD86 and type 1 diabetes mellitus: Although no evidence shows the expression of B7-1/B7-2 (CD80/CD86) on human pancreatic β cells, transgenic overexpression of B7-1 on NOD pancreatic islet accelerates the progression of type 1 diabetes (27, 28).